AzTrials
AzTrials

Tracheal IntubationNCT07165314

Assessment of Provider Position for Prehospital Tracheal Intubation

A study testing Free positioning and Sitting cross-legged ("Lotus" position) in people with Tracheal Intubation, run by University Hospital, Geneva at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Endotracheal intubation may be needed in critically ill patients in the prehospital setting, where difficult conditions may be encountered. The patient may be lying on the ground, thus complicating direct laryngoscopy as the operator's visual axis cannot be properly aligned with the patient's oral-pharyngeal-tracheal… Read more about this study

Who is it for?
Ages 18 to 50 yearsHealthy volunteers can take part
Conditions the study is for
Tracheal Intubation
What is being tested?
Free positioning and Sitting cross-legged ("Lotus" position)
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
72 participants
Where
1 siteSwitzerland
Study dates
1 Sep 2023to 30 Apr 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • All resident doctors with 1 to 6 years of post-graduate experience working in the Emergency Department (ED) at Geneva University Hospitals (Hôpitaux Universitaires de Genève (HUG)) and penultimate year of medical school students (5th year) studying at University of Geneva Faculty of Medicine (UGFM) - Performed less than 10 ETIs prior to take part in the research

Who cannot join

  • More than 6 years of post-graduate experience
  • Performed more than 10 ETIs prior to take part in the research

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Hôpitaux Universitaires de Genève

    Geneva, Canton of Geneva, 1205

Other trials in Switzerland

About this study

Official title: Assessment of Provider Position for Prehospital Tracheal Intubation Using Direct Laryngoscopy: Randomized Controlled Trial

Endotracheal intubation may be needed in critically ill patients in the prehospital setting, where difficult conditions may be encountered. The patient may be lying on the ground, thus complicating direct laryngoscopy as the operator's visual axis cannot be properly aligned with the patient's oral-pharyngeal-tracheal axis. The posture sitting cross-legged ("Lotus" position) at the head of the patient may allow an easier alignment of the visual axes due to a lower operator's head position and more stability. We compared the impact of the "Lotus" position with free positioning of the operator for direct laryngoscopy on intubation first pass success rate among novice operators.

Being tested
Free positioning, Sitting cross-legged ("Lotus" position)
Keywords
advanced airway management, laryngoscopy, sitting position, prehospital, manikin, randomized controlled trial

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Free positioningProcedure or surgery

    Participants are not given instructions on how to position for intubation using direct laryngoscopy.

  • Sitting cross-legged ("Lotus" position)Procedure or surgery

    Participants are requested to sit cross-legged for intubation using direct laryngoscopy.

Study groups in NCT07165314
Study groupRoleWhat they receive
Free positioningActive comparatorNot described
Receives: Procedure: Free positioning
Sitting cross-legged ("Lotus" position)ExperimentalNot described
Receives: Procedure: Sitting cross-legged ("Lotus" position)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. First Pass Success rate

    In percentage, defined as achieving successful ETI on the initial attempt. An ETI attempt was counted since the laryngoscope blade was inserted at the dental arch, regardless of whether tracheal tube placement was attempted or not. ETI was considered successful when adequate ventilation was confirmed by chest elevation. The number of intubation attempts were limited to three, with a time limit of 60 seconds allowed per attempt.

    Measured: Periprocedural

Secondary outcomes (6)
  1. Time to Intubation

    Time in seconds from blade insertion at the dental arch to successful ventilation. A maximum of 60 seconds was allowed per ETI attempt.

    Measured: Periprocedural

  2. Time to Intubation for the first intubation attempt alone

    Time in seconds from blade insertion at the dental arch to adequate ventilation, ruling out first-attempt failures. A maximum of 60 seconds was allowed per ETI attempt.

    Measured: Periprocedural

  3. Number of intubations attempts

    An ETI attempt was counted since the laryngoscope blade was inserted at the dental arch, regardless of whether tracheal tube placement was attempted or not. ETI was considered successful when adequate ventilation was confirmed by chest elevation. The number of intubation attempts were limited to three, with a time limit of 60 seconds allowed per attempt.

    Measured: Periprocedural

  4. Cormack and Lehane (CL) score

    For each attempt, the view of the larynx was assessed by the participant using the Cormack-Lehane score.

    Measured: Periprocedural

  5. Percentage Of Glottis Opening (POGO) score

    For each attempt, the percentage of glottis opening was assessed by the participant, using the POGO score.

    Measured: Periprocedural

  6. Subjective assessments

    Perceived difficulty was appraised using a 5-point Likert scale ranging from "Totally Agree" to "Totally Disagree".

    Measured: Periprocedural

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Sep 2025
  2. Study start1 Sep 2023
  3. Primary completion30 Apr 2024
  4. Study completion30 Apr 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
72 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07165314
Sponsor's protocol ID
Req-2025-01129
Status last verified
Sep 2025
First submitted
2 Sep 2025
Last updated
10 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Free positioning and Sitting cross-legged ("Lotus" position) in people with Tracheal Intubation, run by University Hospital, Geneva at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

First Pass Success rate (time frame: Periprocedural). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in